Shionogi Wins NEDO Award for Quantum-Assisted Drug Discovery
AI-summarised brief · reviewed before publication
Shionogi & Co., a Japanese pharmaceutical firm, won first place in the Quality of Life category of the NEDO Challenge for its quantum‑assisted drug‑discovery research conducted with D‑Wave. A peer‑reviewed study in Scientific Reports (July 2026) showed that a generative AI model integrated with D‑Wave’s annealing quantum computer produced chemically valid molecular representations 97 % of the time, versus 73 % for a comparable classical model, and yielded a higher share of molecules with strong drug‑likeness scores. The ¥40 million prize will fund continued work that blends quantum annealing with classical high‑performance computing to design and evaluate candidate compounds. Researchers say the approach could streamline early‑stage molecule design, potentially shortening the path to new medicines and accelerate clinical testing timelines for future therapies globally.
💡 Why It Matters
- · By proving quantum annealing can lift AI‑generated molecules to near‑clinical relevance, the work offers a concrete shortcut for pharma pipelines that traditionally stall on low‑quality designs.